Cybin CEO on FDA breakthrough designation for psychedelic drug treating MDD

Cybin CEO on FDA breakthrough designation for psychedelic drug treating MDD

Source: 
Medical Marketing and Media
snippet: 


Is a psychedelic revolution afoot in life sciences?

If recent news out of Cybin is any indication, the industry might see the practical application of psychedelics realized sooner than later.